For laboratory research only. Not for human consumption.Our comparison method ↗
Studio-style Deals on Peptides product visual for CJC-1295 (no DAC)

Vial comparison

CJC-1295 (no DAC) prices

Compare research vials explicitly labeled CJC-1295 without DAC. The no-DAC wording is part of the product match, not an optional detail to drop when comparing prices.

29suppliers represented
43source-linked listings
5strengths available

MATCH SIZE AND QUANTITY

Build your comparison.

Daily snapshot · inspect sources

Choose a labeled amount and selection to load matching prices.

GO BEYOND THE PRICE

Track it. Plan it. Inspect it.

Select a strength and selection above to view price history, save a price watch or add it to your basket.

DOCUMENTATION PASSPORTS

Reports and batch records

Search all batch records

Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.

Loading documentation records…

Listed amounts and selections

  • 2 mg2 suppliers · Pack counts: 1
  • 5 mg21 suppliers · Pack counts: 1, 10
  • 8 mg1 supplier · Pack counts: 1
  • 10 mg12 suppliers · Pack counts: 1, 3, 6, 10
  • 11 mg1 supplier · Pack counts: 1

Reported quantities in this family: 1, 3, 6, 10. Counts and units must be matched to the exact listing.

How to compare CJC-1295 (no DAC) listings

This group recognizes labels including CJC-1295 without DAC, CJC-1295 W/O DAC, Mod GRF 1-29 and Modified GRF 1-29. Check the original listing for that identity before matching an offer. A title that says only CJC-1295 does not establish that it belongs in the no-DAC group.

Compare the same labeled amount and pack count; the catalog includes 2 mg, 5 mg and 10 mg no-DAC vials, among other sizes. Keep CJC-1295 with DAC and CJC-1295/Ipamorelin blends separate. A blend's combined milligrams do not establish how much of either component it contains.

Before opening an offer

  • Confirm the supplier explicitly identifies the product as without DAC or uses a recognized no-DAC label.
  • Exclude CJC-1295 with DAC and combinations containing Ipamorelin from this single-compound comparison.
  • Match milligrams per vial and pack count before comparing the total prices.

Single-vial price overview

Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.

Listed total prices before additional promotions or coupon estimates. Includes supplier captures and aggregator reports; capture dates do not confirm current vendor price or stock. Shipping and tax extra. Open the source before relying on a price.
StrengthSelectionLowest listed total pricePrice per mgSupplier countCompare
2 mg1 vial$13.74$6.872Compare
5 mg1 vial$18.69$3.7417Compare
10 mg1 vial$27.49$2.7511Compare
11 mg1 vial$29.14$2.651Compare

Suppliers with CJC-1295 (no DAC) listings

29 profiles
View 23 more supplier profiles

Sources and comparison limits

9 listings from direct supplier captures and 34 listings from aggregator reports. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.

Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.

Questions about this comparison

Why are CJC-1295 with DAC and without DAC shown separately?

They are distinct labels in the catalog, and the comparison does not treat them as equivalent products. The exact DAC designation must match before prices can be compared within this group.

Why might a Mod GRF 1-29 listing appear here?

Mod GRF 1-29 and Modified GRF 1-29 are recognized supplier-label aliases in this index. Read the original product description and documentation to confirm the identity of the specific offer.

Does a 10 mg CJC-1295/Ipamorelin blend equal a 10 mg no-DAC vial?

The shared total does not establish an equivalent selection. A blend includes multiple components; inspect the stated amount of each. This page compares single-compound no-DAC vials separately from those recipes.

Explore more vial listings

Browse all products

FROM PEPTIDES CALCULATOR

About CJC-1295 Without DAC

Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile

ModGRF 1-29 is the 29-residue growth hormone-releasing hormone fragment GRF(1-29) with four amino acid substitutions that ConjuChem introduced in the early 2000s to resist breakdown by DPP-4 and oxidation; it is the peptide half of CJC-1295, which adds a maleimidopropionyl group on an extra lysine so the drug binds albumin and lasts about a week, hence the community names CJC-1295 without DAC or No DAC. The modified fragment itself was characterized in rat pituitary cells and rats during CJC-1295 development, and every human trial used the albumin-binding DAC version, so there is no published human dosing, pharmacokinetic or safety study of the no-DAC peptide. It is sold as a research chemical and used almost always alongside a ghrelin-receptor peptide such as ipamorelin; WADA prohibits GHRH analogues including CJC-1295 at all times, and the FDA listed CJC-1295 among compounding substances that may present significant safety risks from September 2023 until the nomination was withdrawn in April 2026.

Formula
C152 H252 N44 O42
Molar mass
3,367.9 g/mol
CAS number
863288-34-0
Amino acids
29

Research evidence described in the source

Animal

Modified backbone development

Preclinical work characterized modified GRF analogues and the later albumin-bound DAC construct.

Human

Human evidence is mainly DAC-linked

The frequently cited 2006 trial tested long-acting CJC-1295 with DAC, not the no-DAC form (ModGRF 1-29).

Review

No-DAC clinical gap

Direct controlled human pharmacokinetic and outcomes data for the no-DAC product are sparse.

Limitations noted in the source

  • CJC-1295 DAC trial doses and half-life cannot be assigned to the no-DAC form.
  • Product naming is inconsistent and can conceal the presence or absence of the DAC linker.
  • A calculator preset is a recorded research convention, not a recommendation or evidence of clinical benefit.
  • Identity, purity, sterility, and stability can vary substantially outside regulated manufacturing.
Publications and references linked by the source

Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.